Vetnostrum Animal Health Co., Ltd. (TPE:6936)

Taiwan · Delayed Price · Currency is TWD

31.80

+0.05 (0.16%)

At close: Jul 20, 2026

-16.32% (1Y)

Market Cap	2.32B -16.3%
Revenue (ttm)	1.44B +6.6%
Net Income	137.43M -5.0%
EPS	1.90 -13.0%
Shares Out	72.80M
PE Ratio	16.76
Forward PE	n/a
Dividend	1.51 (4.75%)
Ex-Dividend Date	Jun 9, 2026

Volume	29,993
Open	32.05
Previous Close	31.75
Day's Range	31.70 - 32.10
52-Week Range	31.70 - 46.20
Beta	0.09
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 10, 2026

About Vetnostrum Animal Health

Vetnostrum Animal Health Co., Ltd. engages in the import, manufacture, and sale of animal medicines, health food, feed additives, and feed. It offers antibiotics, hormonal preparations, topical disinfectants, and drugs for anti-inflammatory, deworming, anti-fungal, antiprotozoal, etc; vitamins, minerals, and amino acids for regular supplementary; and non-medicated feed additives for swine, cattle and sheep, poultry, pet, and aquatic animals. The company was founded in 2012 and is based in Hsinchu City, Taiwan. Vetnostrum Animal Health Co., Ltd.... [Read more]

Industry Farm Products

Sector Consumer Staples

Founded 2012

Employees 195

Stock Exchange Taiwan Stock Exchange

Ticker Symbol 6936

Full Company Profile

Financial Performance

In 2025, Vetnostrum Animal Health's revenue was 1.42 billion, an increase of 9.43% compared to the previous year's 1.29 billion. Earnings were 128.85 million, a decrease of -5.68%.

Financial Statements